Quest Diagnostics Inc (NYSE:DGX)
$ 153.02 -0.4 (-0.26%) Market Cap: 17.08 Bil Enterprise Value: 23.40 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 86/100

Quest Diagnostics Inc Investor Day Transcript

Mar 16, 2023 / 01:00PM GMT
Release Date Price: $134 (+0.87%)
Unidentified Participant

Ladies and gentlemen, please welcome, Vice President, Investor Relations, Shawn Bevec.

Shawn C. Bevec
Quest Diagnostics Incorporated - VP of IR

Good morning, everyone, and welcome to Quest Diagnostics' 2023 Investor Day. Before we get into the agenda, I just want to run through the safe harbor. I'm not going to read through it. You guys can let it wash over you.

So just a brief bit about our agenda today. Our President and CEO, Jim Davis, is going to kick us off and talk about why Quest is going to drive sustainable growth in a post-pandemic world. Then Mark Gardner will come up next, and he's going to talk about the investments we're making and the things we're doing around molecular genomics and oncology. Then Cathy Doherty will join us. She's going to talk about our Invigorate initiatives and how we're going to continue to drive 3% savings productivity. And then finally, Sam Samad, our CFO, is going to step on stage and deliver the financial outlook and the long-term outlook. And then we'll have plenty of time at the end of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot